AnTix Holdings is a shell-stage technology company in transition, with no meaningful operating revenue in its current form. Its core asset is the Ticketbash AI software platform, acquired in October 2025 for $522,000. The platform targets the event ticketing market — covering concerts, sports, theater, and conferences — and uses machine learning and predictive analytics to help event organizers dynamically price tickets, detect fraud, and optimize seat utilization. AnTix's intended business model is to deploy the Ticketbash platform to venues and event organizers, generating revenue through per-ticket fees and a percentage of ticket prices. AnTix also holds an 80% economic interest in a to-be-formed subsidiary that holds an exclusive license for Oral Thrush, a mouthwash that treats oral fungal infections, which remains in a study phase and has not been commercialized. AnTix's most recent operating business was SarahCare, an adult day care franchisor with locations across 13 states, which AnTix acquired in 2021 and sold in June 2025 for $300,000. As of mid-2025, AnTix had one employee, and its historical financials reflect the now-divested SarahCare operations.